A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV-Reference-Cited by-同舟云学术

A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV

Published:2014-12-13 Issue:11 Volume:253 Page:1867-1872
ISSN:0721-832X
Container-title:Graefe's Archive for Clinical and Experimental Ophthalmology
language:en
Short-container-title:Graefes Arch Clin Exp Ophthalmol

Author:

Pece Alfredo,Milani Paolo,Monteleone Carla,Trombetta Costantino John,De Crecchio Giuseppe,Fasolino Giuseppe,Matranga Domenica,Cillino Salvatore,Vadalà Maria

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/s00417-014-2886-x.pdf

Reference32 articles.

1. Soubrane G (2008) Choroidal neovascularization in pathologic myopia: recent developments in diagnosis and treatment. Surv Ophthalmol 53:121–138

2. Participants VR (2005) Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update. Retina 25:119–134

3. Cohen SY (2009) Anti-VEGF drugs as the 2009 first-line therapy for choroidal neovascularization in pathologic myopia. Retina 29:1062–1066

4. Chan WM, Lai TY, Chan KP et al (2008) Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal Bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia. Retina 28:1308–1313

5. Wolf S, Balciuniene VJ, Laganovska G et al (2014) Radiance study group. radiance: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmology 121(3):682–692

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different approaches for treating myopic choroidal neovascularization: a network Meta-analysis;International Journal of Ophthalmology;2023-12-18

2. Treatment of myopic choroidal neovascularization: a network meta-analysis and review;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-11-11

3. Comparison of anatomical and functional outcomes of treating myopic choroidal neovascularization with bevacizumab or ranibizumab;International Ophthalmology;2023-06-15

4. Comparison of the outcome of limited protocol Ranibizumab injection in naïve choroidal neovascular membranes secondary to pathological myopia versus age-related macular degeneration;Journal of the Egyptian Ophthalmological Society;2023

5. Different approaches for the treatment of myopic choroidal neovascular: a network meta-analysis;2022-09-16